Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation
出版年份 2017 全文链接
标题
Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation
作者
关键词
-
出版物
Nature Communications
Volume 8, Issue -, Pages 14844
出版商
Springer Nature
发表日期
2017-03-28
DOI
10.1038/ncomms14844
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dose-escalation study for the targeting of CD44v+ cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205)
- (2016) Kohei Shitara et al. Gastric Cancer
- Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer
- (2016) Dawid Walerych et al. NATURE CELL BIOLOGY
- An open-label phase I dose-finding study of APR-246 in hematological malignancies
- (2016) S Deneberg et al. Blood Cancer Journal
- Intramuscular Transplantation Improves Engraftment Rates for Esophageal Patient-Derived Tumor Xenografts
- (2015) Matthew Read et al. ANNALS OF SURGICAL ONCOLOGY
- PRIMA-1MET induces death in soft-tissue sarcomas cell independent of p53
- (2015) Thomas Grellety et al. BMC CANCER
- Amino Acid Transporters in Cancer and Their Relevance to "Glutamine Addiction": Novel Targets for the Design of a New Class of Anticancer Drugs
- (2015) Y. D. Bhutia et al. CANCER RESEARCH
- Using CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60
- (2015) W. C. Reinhold et al. CLINICAL CANCER RESEARCH
- APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinoma
- (2015) David S H Liu et al. GUT
- Ferroptosis as a p53-mediated activity during tumour suppression
- (2015) Le Jiang et al. NATURE
- APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells
- (2015) N Mohell et al. Cell Death & Disease
- Anti-oxidative stress response genes: bioinformatic analysis of their expression and relevance in multiple cancers
- (2015) Barak Rotblat et al. Oncotarget
- PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH/ROS balance
- (2014) B. Tessoulin et al. BLOOD
- Regulation of Ferroptotic Cancer Cell Death by GPX4
- (2014) Wan Seok Yang et al. CELL
- Mutant p53 reactivation by small molecules makes its way to the clinic
- (2014) Vladimir J.N. Bykov et al. FEBS LETTERS
- Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
- (2014) Scott J Dixon et al. eLife
- Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies
- (2014) Glenn S Cowley et al. Scientific Data
- Variability in functional p53 reactivation by PRIMA-1Met/APR-246 in Ewing sarcoma
- (2013) D N T Aryee et al. BRITISH JOURNAL OF CANCER
- Characterization of a Novel Tumorigenic Esophageal Adenocarcinoma Cell Line: OANC1
- (2013) Nicholas J. Clemons et al. DIGESTIVE DISEASES AND SCIENCES
- APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase
- (2013) X Peng et al. Cell Death & Disease
- An Optimized microRNA Backbone for Effective Single-Copy RNAi
- (2013) Christof Fellmann et al. Cell Reports
- The Cystine/Glutamate Antiporter System xc− in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities
- (2012) Jan Lewerenz et al. ANTIOXIDANTS & REDOX SIGNALING
- CellMiner: A Web-Based Suite of Genomic and Pharmacologic Tools to Explore Transcript and Drug Patterns in the NCI-60 Cell Line Set
- (2012) W. C. Reinhold et al. CANCER RESEARCH
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- Mutant p53R273Hattenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species
- (2012) Eyal Kalo et al. JOURNAL OF CELL SCIENCE
- Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer
- (2012) Sören Lehmann et al. JOURNAL OF CLINICAL ONCOLOGY
- p53 mutations in cancer
- (2012) Patricia A. J. Muller et al. NATURE CELL BIOLOGY
- Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha
- (2012) B. N. Chorley et al. NUCLEIC ACIDS RESEARCH
- System xc- cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS
- (2011) Richard J Bridges et al. BRITISH JOURNAL OF PHARMACOLOGY
- CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc− and Thereby Promotes Tumor Growth
- (2011) Takatsugu Ishimoto et al. CANCER CELL
- Mutant p53 rescue and modulation of p53 redox state
- (2011) Vladimir J.N. Bykov et al. CELL CYCLE
- Predictive biomarkers: a paradigm shift towards personalized cancer medicine
- (2011) Nicholas B. La Thangue et al. Nature Reviews Clinical Oncology
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain
- (2009) Jeremy M.R. Lambert et al. CANCER CELL
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- Mutant p53 Gain-of-Function in Cancer
- (2009) M. Oren et al. Cold Spring Harbor Perspectives in Biology
- Oncogene Addiction
- (2008) I. B. Weinstein et al. CANCER RESEARCH
- Membrane Redox State and Apoptosis: Death by Peroxide
- (2008) Joseph Loscalzo Cell Metabolism
- Glutathione Peroxidase 4 Senses and Translates Oxidative Stress into 12/15-Lipoxygenase Dependent- and AIF-Mediated Cell Death
- (2008) Alexander Seiler et al. Cell Metabolism
- Regulation of glutathione synthesis
- (2008) Shelly C. Lu MOLECULAR ASPECTS OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now